ScoreWhy is Marksans Pharma Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 10.10% of over the last 5 years
2
Flat results in Dec 25
- ROCE(HY) Lowest at 16.13%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.86 times
3
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -8.16% over the previous quarter and collectively hold 14.04% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 8.81% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -31.73% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Marksans Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Marksans Pharma
-31.22%
-0.75
42.35%
Sensex
7.89%
0.69
11.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.21%
EBIT Growth (5y)
10.10%
EBIT to Interest (avg)
32.25
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
1.13
Tax Ratio
24.11%
Dividend Payout Ratio
8.67%
Pledged Shares
0
Institutional Holding
14.04%
ROCE (avg)
27.77%
ROE (avg)
16.65%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
32
Price to Book Value
2.98
EV to EBIT
17.65
EV to EBITDA
14.43
EV to Capital Employed
3.26
EV to Sales
2.74
PEG Ratio
NA
Dividend Yield
0.45%
ROCE (Latest)
17.72%
ROE (Latest)
13.08%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(Q)
Highest at Rs 754.43 cr
PBDIT(Q)
Highest at Rs 160.75 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 21.31%
PBT LESS OI(Q)
Highest at Rs 130.48 cr.
PAT(Q)
Highest at Rs 113.20 cr.
EPS(Q)
Highest at Rs 2.50
-5What is not working for the Company
ROCE(HY)
Lowest at 16.13%
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.86 times
Loading Valuation Snapshot...
Here's what is working for Marksans Pharma
Net Sales - Quarterly
Highest at Rs 754.43 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 160.75 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 21.31%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 130.48 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 130.48 cr has Grown at 30.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 99.72 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 113.20 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 113.20 cr has Grown at 28.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 87.92 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.50
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Marksans Pharma
Inventory Turnover Ratio- Half Yearly
Lowest at 2.86 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
